What we know about statins comes almost entirely from commercial interests. So what we take for knowledge about their harms and benefits is actually information designed to optimise the drug makers’ responsibility…
- Lecturer on Health Care Policy, Harvard University
Nearly 13m more adults in the US will be eligible for statins after new guidelines widened the criteria for use of the drugs to treat high cholesterol and prevent heart attacks and strokes. Using data…
Contact John for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
